Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants [Phase 3]

View source ↗

Summary

Phase 3 immunogenicity update evaluating antibody persistence and booster response of the DTaP-HB PRP-T combination vaccine in Filipino infants. The study was c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTaP-HB PRP-T vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2013-11-14